New rabies vaccine candidate demonstrates promising immune response and safety
Researchers from the University of Oxford have today reported new findings from a Phase 1 clinical trial studying the immune response and safety of their newly-developed single shot rabies vaccine, ChAdOx2 RabG—with promising ...
Jul 28, 2022
0
101